FDA and ISMP partner to help consumers prevent medication errors


The US Food and Drug Administration (FDA) and the nonprofit Institute for Safe Medication Practices (ISMP) have long shared a common goal of helping consumers prevent medication errors. Now, to reach as many consumers as possible, FDA’s Center for Drug Evaluation and Research (CDER) has formally strengthened its relationship with ISMP so the two agencies can work together to provide consumers with information on how to use medicines safely.

Discussing various medication error topics and timely posting of crucial information on both agencies’ websites are just two of the ways that ISMP and FDA are working together towards this goal. For example, late in 2011, both FDA and ISMP received reports of dosing confusion involving a new, less concentrated form of acetaminophen for infants. A more complete picture of the problem was possible by combining the reports submitted to both agencies. Then, ISMP and FDA both issued advisories with tips to help consumers avoid confusion and dosing errors. Click here to link to ISMP’s advisory on this topic, or click here to listen to the FDA podcast about infant acetaminophen safety.

Also, this website—ISMP’s  ConsumerMedSafety.orgoffers a new, dedication section for FDA consumer alerts, videos, and special communications related to drug safety. Click here to go to this section, where you will find a wide assortment of important FDA consumer advisories and videos ranging from accidental testosterone exposure in women to mercury poisoning from skin products. Or watch a video on how to teach kids about using medications safely. This video, and others, are also provided in Spanish.

Check this website frequently to stay informed about important FDA and ISMP safety alerts. Be sure to visit the site often!

Created on April 26, 2012

Medication Safety Alerts

FDA Safety Alerts

Show Your Support!

ISMP needs your help to continue our life saving work